IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

CASSIN, RAMONA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.894
NA - Nord America 2.052
AS - Asia 2.015
SA - Sud America 205
AF - Africa 66
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.255
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.978
DE - Germania 1.282
SG - Singapore 591
IT - Italia 565
CN - Cina 551
GB - Regno Unito 336
BD - Bangladesh 239
HK - Hong Kong 173
SE - Svezia 162
BR - Brasile 161
VN - Vietnam 142
RU - Federazione Russa 122
IN - India 108
FR - Francia 106
IE - Irlanda 71
NL - Olanda 69
CA - Canada 56
JP - Giappone 50
TR - Turchia 43
FI - Finlandia 41
CI - Costa d'Avorio 35
ID - Indonesia 32
CH - Svizzera 21
AU - Australia 20
UA - Ucraina 20
DK - Danimarca 19
ES - Italia 17
PL - Polonia 15
BE - Belgio 13
KR - Corea 13
MX - Messico 13
PH - Filippine 12
AR - Argentina 10
SA - Arabia Saudita 10
ZA - Sudafrica 9
CO - Colombia 8
IQ - Iraq 8
EG - Egitto 7
IR - Iran 7
CZ - Repubblica Ceca 6
PK - Pakistan 6
TH - Thailandia 6
AT - Austria 5
CL - Cile 5
EC - Ecuador 5
LT - Lituania 5
PE - Perù 5
PY - Paraguay 5
DZ - Algeria 4
IL - Israele 4
LU - Lussemburgo 4
HU - Ungheria 3
TW - Taiwan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
JO - Giordania 2
KG - Kirghizistan 2
LK - Sri Lanka 2
MY - Malesia 2
NZ - Nuova Zelanda 2
PT - Portogallo 2
QA - Qatar 2
SC - Seychelles 2
SN - Senegal 2
TN - Tunisia 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
EU - Europa 1
FK - Isole Falkland (Malvinas) 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JM - Giamaica 1
KW - Kuwait 1
LB - Libano 1
LV - Lettonia 1
MA - Marocco 1
ML - Mali 1
MU - Mauritius 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
YT - Mayotte 1
Totale 7.255
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 1.117
Singapore 361
Southend 283
Ashburn 280
Chandler 190
Hong Kong 161
San Jose 114
Milan 110
Dallas 106
New York 84
Beijing 79
Dublin 70
Fairfield 70
Council Bluffs 62
Princeton 61
Wilmington 61
Los Angeles 58
Rome 49
Hanoi 48
Hanover 47
Santa Clara 45
Ann Arbor 43
Boardman 37
Abidjan 35
Ho Chi Minh City 33
Seattle 33
Woodbridge 33
Buffalo 30
Dearborn 30
Istanbul 30
Houston 29
Lauterbourg 29
Bengaluru 28
Toronto 28
Helsinki 25
Munich 25
Tokyo 24
Jakarta 23
The Dalles 23
Cambridge 22
Des Moines 21
Moscow 19
Nanjing 18
Phoenix 18
Cangzhou 17
Guangzhou 17
Turin 17
Columbus 16
Genoa 15
Hefei 15
Sydney 15
Jinan 14
Redwood City 14
Bari 13
Brussels 13
Shanghai 13
Shenyang 13
Hyderabad 12
Atlanta 11
Chicago 11
São Paulo 11
Tianjin 11
Catania 10
London 10
Mannheim 10
Nuremberg 10
Chennai 9
Deiva Marina 9
Kent 9
Montreal 9
Mumbai 9
Naples 9
Paris 9
Berlin 8
Brooklyn 8
Fuzhou 8
Redondo Beach 8
Warsaw 8
Ankara 7
Bexley 7
Changsha 7
Hangzhou 7
Madrid 7
Orem 7
Polcenigo 7
San Diego 7
Turku 7
Brasília 6
Brno 6
Denver 6
Grafing 6
Johannesburg 6
New Delhi 6
Salerno 6
Seoul 6
Stockholm 6
Tehran 6
Wuhan 6
Bitonto 5
Cairo 5
Totale 4.622
Salva come PNG Salva come JPEG
Nome #
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine. Results of study on 486 cases outside clinical trials 500
Assessment of the 4-factor score : Retrospective analysis of 586 CLL patients receiving ibrutinib : A campus CLL study 470
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 342
Ensuring continuity of care of hematologic patients during COVID-19 pandemic in a tertiary hospital in Lombardy (Italy) 339
Biological and molecular characterization of a rare case of cutaneous Richter syndrome 279
IgA hypogammaglobulinemia predicts outcome in chronic lymphocytic leukemia 272
Multifactorial neutropenia in a patient with acute promyelocytic leukemia and associated large granular lymphocyte expansion: A case report 264
Beta-thalassaemia intermedia : evaluation of endocrine and bone complications 260
Predictors of atrial fibrillation in ibrutinib-treated CLL patients : a prospective study 250
Impact of bone marrow fibrosis in response to azacitidine in 94 patients with myelodisplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and acute myeloid leukemia 244
Impact of Bone Marrow Fibrosis and Early Response on Outcome after Azacitidine Therapy in 94 Patients with Myelodisplastic Syndromes, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia 236
Low-dose Alemtuzumab in Refractory/Relapsed Chronic Lymphocytic Leukemia : Genetic Profile and Long-term Outcome from a Single Center Experience 233
Comprehensive Biological and Molecular Characterization of a RARE Case of Cutaneous Richter Syndrome 233
Decitabine treatment for an unusual case of atypical chronic myeloid leukemia (aCML) with a concomitant chronic lymphocytic leukemia (CLL) 231
Eltrombopag in Immune Thrombocytopenia, Aplastic Anemia, and Myelodysplastic Syndrome : From Megakaryopoiesis to Immunomodulation 228
Bone Marrow Fibrosis and Early Hematological Response as Predictors of Poor Outcome in Azacitidine Treated High Risk-Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia 225
Treating chronic lymphocytic leukemia with obinutuzumab: safety and efficacy considerations 211
Idelalisib rapidly improves platelet function tests in patients with chronic lymphocytic leukaemia 196
Idelalisib Rapidly Improves Platelets Function in Patients with Chronic Lymphocytic Leukemia (CLL) 178
Atrial Fibrillation (AF) and Ibrutinib, a Monocentric Experience: Should Cardiological Evaluation be a Guide in Clinical Practice? 177
Hypogammaglobulinemia in Chronic Lymphocytic Leukemia: A Predictor of Outcome? 175
Heminsight to assess patient reported outcomes of patients affected by chronic lymphocytic leukemia in daily clinical practice 175
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment With Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 174
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients 173
Hypogammaglobulinemia is a strong predictor of time to first treatment in chronic lymphocytic leukemia 165
Immunomodulatory drugs : new options for the treatment of myelodysplastic syndromes 164
Effect of ibrutinib treatment on hemolytic anemia and acrocyanosis in cold agglutinin disease/cold agglutinin syndrome 163
Bone quality in beta-thalassemia intermedia : relationships with bone quantity and endocrine and hematologic variables 160
Safety Profile and Outcomes of Early COVID-19 Treatments in Immunocompromised Patients: A Single-Centre Cohort Study 156
Secondary malignancies in chronic lymphocytic leukemia: a single centre retrospective analysis 155
Chronic lymphocytic leukemia and prognostic models : a bridge between clinical and biological markers 154
Lymphocytic infiltrate and p53 protein expression as predictive markers of response and outcome in myelodysplastic syndromes treated with azacitidine 143
Secondary Malignancies in Chronic Lymphocytic Leukemia: A Single Centre Retrospective Analysis of 514 Cases 137
Totale 7.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022516 40 30 82 20 28 28 8 43 58 32 53 94
2022/2023734 85 74 70 79 73 122 16 51 77 12 49 26
2023/20241.217 28 37 47 39 126 55 181 154 83 143 173 151
2024/20251.482 147 211 109 193 80 39 38 99 70 143 120 233
2025/20262.552 272 174 223 212 209 116 251 68 238 152 347 290
2026/20273 3 0 0 0 0 0 0 0 0 0 0 0
Totale 7.462